Zymedyne – University of Calgary collaboration receives major AICE funding award from Alberta Innovates
Zymedyne Therapeutics is pleased to announce that a 3 year $600,000 AICE Concepts grant from Alberta Innovates has been secured to support critical research at the University of Calgary in support of our drug development program. AICE (Accelerating Innovations into CarE) grants are designed to enable and accelerate early-stage innovators from ideation to conceptualizing across the four domains of commercialization. Alberta Innovates is a provincial organization that “expands the horizon of possibilities to solve today’s challenges and create a healthier and more prosperous future for Alberta and the world.” Current AICE Projects (Including Zymedyne): https://albertainnovates.ca/current-aice-projects/ Learn more more about AICE here: Alberta Innovates on Twitter: https://twitter.com/ABInnovates
UCEED OPPORTUNITY HEALTH FUND AWARD
Zymedyne Therapeutics is pleased to announce it has been awarded a UCEED Opportunity Fund Award from University of Calgary. Implemented by Innovate Calgary, the university’s knowledge transfer and business incubator, UCEED serves to support U of Calgary-based child and health enterprises and help commercialize new technologies and accelerate U Calgary start-up companies. Link to the UCEED Opportunity Fund Award Here